Conference report: 2nd Medicon valley inhalation symposium

Therapeutic Delivery

Volumn 5, Issue 2, 2014, Pages 119-121

  Lastow, Orest ^a  

^a Medicon Valley Inhalation Consortium   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FUMARYL DIKETOPIPERAZINE; INSULIN; PIPERAZINEDIONE; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; ELECTRONIC SENSOR; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PRODUCT DEVELOPMENT;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; EQUIPMENT DESIGN; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MEDICATION ADHERENCE; NEBULIZERS AND VAPORIZERS; PHARMACEUTICAL PREPARATIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84893290893     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.13.140     Document Type: Conference Paper

References (6)

1. Cassidy, JP, Baughman RA, Schwartz SL et al. Afresa (Technosphere® insulin) dosage strengths are interchangeable. Presented at: 69th Scientific Sessions. New Orleans, LA, USA, 5-9 June 2009.
2. Lee JJ, Dassau E, Zisser H, Harvey RA, Jovanovi L, Doyle III FJ. In silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control. J. Diabetes Sci. Technol. 7(1), 215-226 (2013).
3. Grant M, Leone-Bay A. Peptide therapeutics: it's all in the delivery. Ther. Deliv. 3(8), 981-996 (2012).
4. Marino MT, Cassidy JP, Smutney CC et al. Poster 107: improvement in bioavailability of FDKP and insulin with the NGDSB device. Presented at: Third International Conference on Advanced Technologies and Treatments for Diabetes. Basel, Switzerland, 10-13 February 2010.
5. Marino MT, Cassidy JP, Smutney CC et al. Poster: bioequivalence and dose proportionality of Afrezza® inhalation powder administered using a Gen2 inhaler compared to the MedTone® inhaler. Presented at: The 10th Annual Diabetes Technology Meeting. Bethesda, MD, USA, 11-13 November 2010.
6. Cassidy JP, Marino MT, Amin N et al. Lung deposition and absorption of insulin from Afresa™ (Technosphere® insulin). Diabetes 58(Suppl. 1), A115 (2009).